BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21830880)

  • 21. Novel amino acids indices based on quantum topological molecular similarity and their application to QSAR study of peptides.
    Hemmateenejad B; Yousefinejad S; Mehdipour AR
    Amino Acids; 2011 Apr; 40(4):1169-83. PubMed ID: 20852906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative structure-activity relationship study of bitter di- and tri-peptides including relationship with angiotensin I-converting enzyme inhibitory activity.
    Wu J; Aluko RE
    J Pept Sci; 2007 Jan; 13(1):63-9. PubMed ID: 17117396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A New Descriptor of Amino Acids-SVGER and its Applications in Peptide QSAR.
    Tong J; Li L; Bai M; Li K
    Mol Inform; 2017 May; 36(5-6):. PubMed ID: 27739658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring QSAR for substituted 2-sulfonyl-phenyl-indol derivatives as potent and selective COX-2 inhibitors using different chemometrics tools.
    Khoshneviszadeh M; Edraki N; Miri R; Hemmateenejad B
    Chem Biol Drug Des; 2008 Dec; 72(6):564-74. PubMed ID: 19090923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting the activity of antimicrobial peptides with amino acid topological information.
    Shu M; Yu R; Zhang Y; Wang J; Yang L; Wang L; Lin Z
    Med Chem; 2013 Feb; 9(1):32-44. PubMed ID: 22741801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative structure-activity relationship study of bitter peptides.
    Kim HO; Li-Chan EC
    J Agric Food Chem; 2006 Dec; 54(26):10102-11. PubMed ID: 17177547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting the activity of ACE inhibitory peptides with a novel mode of pseudo amino acid composition.
    Shu M; Cheng X; Zhang Y; Wang Y; Lin Y; Wang L; Lin Z
    Protein Pept Lett; 2011 Dec; 18(12):1233-43. PubMed ID: 21728992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the activity space of peptides binding to diverse SH3 domains using principal property descriptors derived from amino acid rotamers.
    He P; Wu W; Yang K; Jing T; Liao KL; Zhang W; Wang HD; Hua X
    Biopolymers; 2011; 96(3):288-301. PubMed ID: 20690173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A segmented principal component analysis-regression approach to quantitative structure-activity relationship modeling.
    Hemmateenejad B; Elyasi M
    Anal Chim Acta; 2009 Jul; 646(1-2):30-8. PubMed ID: 19523553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of variable selection on the modelling of oestrogenicity.
    Ghafourian T; Cronin MT
    SAR QSAR Environ Res; 2005; 16(1-2):171-90. PubMed ID: 15844449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TMACC: interpretable correlation descriptors for quantitative structure-activity relationships.
    Melville JL; Hirst JD
    J Chem Inf Model; 2007; 47(2):626-34. PubMed ID: 17381177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A DFT-based QSAR study of the toxicity of quaternary ammonium compounds on Chlorella vulgaris.
    Zhu M; Ge F; Zhu R; Wang X; Zheng X
    Chemosphere; 2010 Jun; 80(1):46-52. PubMed ID: 20417544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retention prediction of peptides based on uninformative variable elimination by partial least squares.
    Put R; Daszykowski M; Baczek T; Vander Heyden Y
    J Proteome Res; 2006 Jul; 5(7):1618-25. PubMed ID: 16823969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Megavariate analysis of environmental QSAR data. Part I--a basic framework founded on principal component analysis (PCA), partial least squares (PLS), and statistical molecular design (SMD).
    Eriksson L; Andersson PL; Johansson E; Tysklind M
    Mol Divers; 2006 May; 10(2):169-86. PubMed ID: 16770514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative structure-activity relationship modeling of renin-inhibiting dipeptides.
    Udenigwe CC; Li H; Aluko RE
    Amino Acids; 2012 Apr; 42(4):1379-86. PubMed ID: 21246225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives.
    Mandal AS; Roy K
    Eur J Med Chem; 2009 Apr; 44(4):1509-24. PubMed ID: 18760864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring QSARs for inhibitory activity of non-peptide HIV-1 protease inhibitors by GA-PLS and GA-SVM.
    Deeb O; Goodarzi M
    Chem Biol Drug Des; 2010 May; 75(5):506-14. PubMed ID: 20486937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. VSMP: a novel variable selection and modeling method based on the prediction.
    Liu SS; Liu HL; Yin CS; Wang LS
    J Chem Inf Comput Sci; 2003; 43(3):964-9. PubMed ID: 12767155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative structure-activity relationship studies on 2-amino-6-arylsulfonylbenzonitriles as human immunodeficiency viruses type 1 reverse transcriptase inhibitors using descriptors obtained from substituents and whole molecular structures.
    Hemmateenejad B; Sabet R; Fassihi A
    Chem Biol Drug Des; 2009 Oct; 74(4):405-15. PubMed ID: 19691465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linear indices of the "molecular pseudograph's atom adjacency matrix": definition, significance-interpretation, and application to QSAR analysis of flavone derivatives as HIV-1 integrase inhibitors.
    Marrero-Ponce Y
    J Chem Inf Comput Sci; 2004; 44(6):2010-26. PubMed ID: 15554670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.